Elastomeric Infusion Pumps Companies

The elastomeric infusion pumps market is expected to reach USD 1.49 billion by 2030 from USD 1.15 billion in 2025, at a CAGR of 5.3% during the forecast period.

The market for elastomeric infusion pumps is growing, driven by the increasing use in oncology, pain relief, palliative care, and the treatment of chronic diseases. These non-electronic systems provide continuous and accurate medication administration to patients, enhancing the safety and reliability of the patient experience in both the healthcare system and the home care setting. They are widely used in the delivery of chemotherapy, analgesics, antibiotics, and other medications that require prolonged administration, while also minimizing the risk of missed doses and allowing patients to move about freely while adhering to their treatment regimen. Elastomeric infusion delivery devices are a Class 2 regulated device, as governed by the international standard that regulates medical devices, including the U.S. FDA, the European Medicines Agency (EMA), and ISO 28620, which helps ensure meeting standards for quality, sterility, and accuracy. The growing focus on patient-centered care, usability, and material sustainability fosters innovations that diminish environmental impact while enhancing treatment efficiency and compliance, rendering elastomeric infusion pumps vital instruments in modern healthcare.

Elastomeric Infusion Pumps Companies

The demand for elastomeric infusion pumps is mainly met by global players manufacturing for various applications. The major players in the elastomeric infusion pumps market with a significant global presence are Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), and Vygon (France). Market players have adopted various strategies, including expansions, partnerships, collaborations, mergers, and acquisitions, to strengthen their position in the elastomeric infusion pumps market.

In October 2024, Nipro Trading (Shanghai), a subsidiary of NIPRO, acquired a 70% stake in Sichuan Pure Science and Technology Co., Ltd., a manufacturer of dialysis and infusion-related equipment.

To know about the assumptions considered for the study download the pdf brochure

Baxter (US) is a global healthcare company dedicated to developing, producing, and providing vital medical products, devices, and treatments to meet the demands of acute and chronic healthcare. It operates in three primary segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. The Medical Products & Therapies segment provides sterile IV solutions, infusion systems and pumps, parenteral nutrition, surgical hemostats, sealants, and products related to adhesion prevention. Healthcare Systems & Technologies offers smart bed systems, patient monitoring and diagnostic devices, respiratory health products, and advanced surgical products. The Pharmaceuticals segment provides specialty injectables, inhaled anesthetics, and drug compounding services. Baxter serves hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, physicians’ offices, dialysis centers, and home care patients under the supervision of a physician. The company has 50 manufacturing factories in 20 countries and sales in over 100 countries; with Baxter's global scale, they increase access to care. Some of its most recognized subsidiaries include Baxter Healthcare Corporation (US), Baxter Corporation (Canada), Baxter Oncology GmbH (Germany), Baxter S.p.A. (Italy), Baxter AG (Switzerland), Baxter Healthcare (Suzhou) Co. Ltd. (China), Baxter Limited (Japan), Baxter (India) Pvt. Ltd., and Baxter Hospitalar Ltda. (Brazil).

B. Braun SE (Germany) is a global healthcare and medical technology enterprise providing extensive solutions in infusion therapy, anesthesia, surgical and interventional procedures, extracorporeal blood treatment, and chronic care management. It functions through three primary divisions: Hospital Care, Aesculap, and Avitum. The Hospital Care branch offers infusion and nutrition therapy, pain management, and anesthetic services. Aesculap specializes in surgical and interventional technologies, encompassing minimally invasive procedures, joint replacements, neurosurgery solutions, and cardiovascular interventions. Avitum develops therapeutic solutions for dialysis and chronic care, enhancing patient quality of life through breakthrough innovations, such as the OMNI dialysis equipment, which features VR training for critical care personnel. B. Braun operates in 64 countries, owns over 300 companies, and maintains a robust global manufacturing and research and development presence. Primary production and research locations span Germany, Brazil, China, France, India, Malaysia, Poland, Switzerland, Spain, Hungary, the United States, the Dominican Republic, and Vietnam, enabling the company to provide innovative healthcare solutions and support to healthcare professionals worldwide.

Nippon (Japan) is a global manufacturer and supplier of healthcare and pharmaceutical solutions, operating within three primary sectors: Medical-Related, Pharmaceutical-Related, and Pharmaceutical Packaging. The Medical-Related segment supplies devices for injection, infusion, dialysis, diabetes control, and artificial organ products. The pharmaceutical firm operates as a leading Contract Development and Manufacturing Organization (CDMO), specializing in the manufacture of oral pharmaceuticals, injectables, and topical formulations for international clients. Nipro manufactures and distributes a diverse array of pharmaceutical packaging products, including glass containers, via its Pharma Packaging division. Nipro operates through over 150 subsidiaries and facilities in more than 40 countries, encompassing Japan, the Americas, Europe, Africa, and Asia. These entities are involved in the development, manufacturing, sales, and management of medical devices, medicines, and pharmaceutical packaging, as well as the operation of dialysis clinics, demonstrating the company's extensive global reach and expertise in healthcare and life sciences. The company supplies elastomeric pumps and additional medical devices through Nipro Europe Group Companies.

AVNS (US), also known as Avanos Medical, Inc., is a medical technology company dedicated to providing innovative device solutions that enhance recovery and improve patients’ quality of life. The company tackles essential healthcare challenges, such as facilitating meals from hospital to home and mitigating narcotic consumption in post-surgical treatment. Avanos offers solutions in Digestive Health and Pain Management and Recovery under its sole reportable sector. Digestive Health provides products such as MIC-KEY enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The Pain Management and Recovery segment encompasses surgical pain and recovery systems, including ON-Q and ambIT pumps, as well as Game Ready cold and compression therapy devices. Additionally, it includes interventional pain solutions such as COOLIEF therapy, OrthogenRx knee osteoarthritis injections, and Trident RFA systems for chronic pain management. Avanos operates production sites in the United States and Mexico.

Vygon (France) is an international medical technology group committed to the design, production, and delivery of innovative single-use medical devices that enhance patient care and healthcare productivity. The company offers a comprehensive solution across various medical specialties, including vascular access, enteral feeding, respiratory therapy, surgery, urinary management, nervous system applications, and patient monitoring. Vygon maintains a total of 11 manufacturing plants located in Europe, South America, and Asia, ensuring quality assurance and the ability to meet the regional needs of health systems. The company has a presence in 26 countries through its subsidiaries and sells its products in a commercial manner in over 120 markets, maintaining close contact with hospitals and healthcare professionals worldwide. Based on its core values of proximity, reliability, and innovation, Vygon continues to develop its reputation as a reliable global partner, providing high-quality medical products that enhance patient healthcare while promoting environmental and social responsibility in all aspects of its business.

MARKET RANKING

The market for elastomeric infusion pumps is fragmented, with major players including Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), and Vygon (France), which collectively hold a significant share of the global market. Baxter offers a comprehensive range of elastomeric and infusion pump products for oncology, pain management, and home healthcare. These products are designed to be more integrated, particularly in the area of workflow efficiency, while providing advanced technology to enhance patient safety and ease. B. Braun SE provides a range of infusion therapy and pump solutions focused on minimally invasive, patient-centric care and chronic illness management. NIPRO offers a range of elastomeric pumps, demonstrating attention to detail in terms of accuracy and mobility. AVNS specializes in flexible elastomeric infusion systems for chemotherapy, pain management, and supportive care, with improvements in dosing accuracy. Vygon offers patient-friendly pumps for both home and hospital use, featuring advanced safety features and biocompatible materials to prevent dosing errors and promote treatment adherence.

Related Reports:

Elastomeric Infusion Pumps Market by Type (Continuous Rate and Variable Rate), Application (Chemotherapy, Pain Management, Antibiotics), End-use Industry (Hospitals, Ambulatory Surgical Centers, Home-care Settings), and Region - Global Forecast to 2030